Remote diabetes care study for adults with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new way of managing type 1 diabetes remotely, where your glucose data is shared with your diabetes team. It aims to see if this approach helps you maintain good glucose control and reduces the need for frequent hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with type 1 diabetes for at least 1 year.
- You use insulin injections (multiple daily) or an insulin pump.
- You have a glucose monitor (CGM) that connects to a smartphone app.
- Your recent glucose levels are well controlled: HbA1c below 53 mmol/mol, time in range over 70%, time below range less than 4%, time above range less than 25%.
- You are willing to share your glucose data remotely with the diabetes team at Tampere University Hospital and do not have other serious medical conditions requiring regular specialist care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if type 1 diabetes can be confirmed through a remote process rather than in-person visits. It may help make follow-up care easier for people with type 1 diabetes.
This study tests an app-based diabetes education program for people with type 1 diabetes. It aims to see if the app can help you manage your blood sugar levels better using insulin pens and a continuous glucose monitor.
This study is testing a new wearable sensor that tracks both glucose (sugar) and ketone levels continuously. It might help people with type 1 diabetes manage their condition better and avoid complications.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests a 6-month online education and support program to help adults manage type 1 diabetes using insulin pump therapy or multiple daily insulin shots. It may help you improve understanding, day-to-day decision-making, and diabetes self-care with ongoing check-ins.
This trial tests whether using remote monitoring can help people with diabetes better control their blood sugar. Participants use a device or app to share blood sugar readings with their care team, which may lead to more tailored treatment.
Hear when a new Glucose Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.